Search Results

Overview

Uniprot IDP0DOX7
Protein NameImmunoglobulin kappa light chain
Gene Name-
OrganismHomo sapiens

Kla Sites from experimental identification

Position Flanking peptide
145 NFYPREAKVQWKVDN
149 REAKVQWKVDNALQS
169 SVTEQDSKDSTYSLS
183 SSTLTLSKADYEKHK
190 KADYEKHKVYACEVT
207 GLSSPVTKSFNRGEC

Function

Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268)

Protein Sequence

10 DIQMTQSPST 20 LSASVGDRVT 30 ITCRASQSIN 40 TWLAWYQQKP 50 GKAPKLLMYK 60 ASSLESGVPS 70 RFIGSGSGTE 80 FTLTISSLQP 90 DDFATYYCQQ 100 YNSDSKMFGQ 110 GTKVEVKGTV 120 AAPSVFIFPP 130 SDEQLKSGTA 140 SVVCLLNNFY 150 PREAKVQWKV 160 DNALQSGNSQ 170 ESVTEQDSKD 180 STYSLSSTLT 190 LSKADYEKHK 200 VYACEVTHQG 210 LSSPVTKSFN RGEC

Gene Ontology

Classification GO ID Description
Cellular Component GO:0005576 extracellular region
Cellular Component GO:0019814 immunoglobulin complex
Cellular Component GO:0005886 plasma membrane
Biological Process GO:0002250 adaptive immune response

Reference

[1] Yang Z, Yan C, Ma J, Peng P, Ren X et al.. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.. Nat Metab 5(1):61-79. 2023 Jan. PMID: 36593272.